Interleukin-1 and Cancer Progression
Author Information
Author(s): Lewis Anne M, Varghese Sheelu, Xu Hui, Alexander H Richard
Primary Institution: National Cancer Institute, Bethesda, Maryland, USA
Hypothesis
The review focuses on the role of interleukin-1 in tumor progression and the potential of interleukin-1 receptor antagonist as a therapeutic agent in cancer treatment.
Conclusion
Interleukin-1 promotes tumor growth, angiogenesis, and metastasis, and its inhibition may provide a novel therapeutic approach in cancer treatment.
Supporting Evidence
- High concentrations of interleukin-1 in tumors are linked to worse patient outcomes.
- Interleukin-1 receptor antagonist has shown promise in reducing tumor growth in animal models.
- Chronic inflammation is associated with the development of many cancers.
Takeaway
Interleukin-1 is a substance in the body that can help tumors grow, but blocking it might help treat cancer.
Methodology
The review summarizes existing studies on interleukin-1's role in cancer and the effects of its antagonist.
Limitations
The review does not provide new experimental data but summarizes existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website